{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:01:20Z","timestamp":1792789280769,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.medcli.2024.01.045","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T20:15:29Z","timestamp":1715026529000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Invasive aspergillosis: A comprehensive review"],"prefix":"10.1016","volume":"163","author":[{"given":"Marina","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.01.045_bib0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.idc.2015.10.015","article-title":"Invasive aspergillosis: current strategies for diagnosis and management","volume":"30","author":"Cadena","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medcli.2024.01.045_bib0310","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medcli.2024.01.045_bib0315","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11046-014-9811-z","article-title":"Treatment of infections by cryptic Aspergillus species","volume":"178","author":"Nedel","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.medcli.2024.01.045_bib0320","first-page":"1","article-title":"Invasive aspergillosis and the impact of azole-resistance","author":"Bosetti","year":"2023","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.medcli.2024.01.045_bib0325","doi-asserted-by":"crossref","first-page":"1170e1","DOI":"10.1016\/j.cmi.2020.09.042","article-title":"Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain","volume":"27","author":"Escribano","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medcli.2024.01.045_bib0330","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.medcli.2024.01.045_bib0335","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13756-019-0543-1","article-title":"Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study","volume":"8","author":"Park","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.medcli.2024.01.045_bib0340","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus infections","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0345","article-title":"Aspergillosis in chronic granulomatous disease","volume":"2","author":"King","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0350","article-title":"Invasive fungal infections after anti-CD19 chimeric antigen receptor-modified T-cell therapy: state of the evidence and future directions","volume":"7","author":"Garner","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0355","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/14787210.2022.2128762","article-title":"Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis","volume":"20","author":"Telli Dizman","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medcli.2024.01.045_bib0360","article-title":"Invasive fungal infections and targeted therapies in hematological malignancies","volume":"7","author":"Little","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0365","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1097\/HS9.0000000000000309","article-title":"Invasive aspergillosis in patients treated with ibrutinib","volume":"4","author":"Furstenau","year":"2020","journal-title":"Hemasphere"},{"key":"10.1016\/j.medcli.2024.01.045_bib0370","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/myc.13298","article-title":"Invasive aspergillosis in solid organ transplantation: diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)","volume":"64","author":"Gioia","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0375","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12879-021-05958-3","article-title":"Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response","volume":"21","author":"Neofytos","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0380","first-page":"7","article-title":"Does post-transplant cytomegalovirus increase the risk of invasive aspergillosis in solid organ transplant recipients? A systematic review and meta-analysis","author":"Chuleerarux","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.medcli.2024.01.045_bib0390","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection \u2013 position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0395","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.medcli.2024.01.045_bib0400","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11046-021-00539-z","article-title":"Respiratory mycoses in COPD and bronchiectasis","volume":"186","author":"Tiew","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.medcli.2024.01.045_bib0405","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12890-020-01259-8","article-title":"The global impact of Aspergillus infection on COPD","volume":"20","author":"Hammond","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0410","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/myc.13274","article-title":"Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches","volume":"64","author":"Jenks","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0420","first-page":"7","article-title":"Influenza- and COVID-19-associated pulmonary aspergillosis: are the pictures different?","author":"Reizine","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0425","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0430","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medcli.2024.01.045_bib0435","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0440","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0445","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2014.05.003","article-title":"Invasive pulmonary aspergillosis in heart transplant recipients: two radiologic patterns with a different prognosis","volume":"33","author":"Munoz","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.medcli.2024.01.045_bib0450","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/crj.13229","article-title":"Is bronchoscopic view a reliable method in diagnosis of tracheobronchial aspergillosis in critically ill non-neutropenic patients?","volume":"14","author":"Youssif","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.medcli.2024.01.045_bib0455","doi-asserted-by":"crossref","first-page":"e01772","DOI":"10.1016\/j.idcr.2023.e01772","article-title":"Progression of chronic rhinosinusitis to invasive cerebro-orbital aspergillosis following steroid treatment: a case of induced immunosuppression","volume":"32","author":"Sawhney","year":"2023","journal-title":"IDCases"},{"key":"10.1016\/j.medcli.2024.01.045_bib0460","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0465","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.medcli.2024.01.045_bib0470","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medcli.2024.01.045_bib0475","doi-asserted-by":"crossref","first-page":"e0216921","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delliere","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medcli.2024.01.045_bib0480","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.cmi.2021.02.005","article-title":"Serology anno 2021-fungal infections: from invasive to chronic","volume":"27","author":"Lass-Florl","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medcli.2024.01.045_bib0485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2018.08.005","article-title":"The performance of galactomannan in combination with 1,3-beta-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies","volume":"93","author":"Zhang","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0490","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14737159.2020.1820864","article-title":"Point-of-care diagnostics for invasive aspergillosis: nearing the finish line","volume":"20","author":"Jenks","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.medcli.2024.01.045_bib0495","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14737159.2018.1488589","article-title":"Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care","volume":"18","author":"McCarthy","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.medcli.2024.01.045_bib0500","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/myc.13451","article-title":"Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: a comparison of galactomannan, mannan and beta-1,3-d-gucan testing from serum and cerebrospinal fluid","volume":"65","author":"Forster","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0505","doi-asserted-by":"crossref","first-page":"e0236095","DOI":"10.1371\/journal.pone.0236095","article-title":"Comparative performance evaluation of Wako beta-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases","volume":"15","author":"De Carolis","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.medcli.2024.01.045_bib0510","article-title":"Evaluation of three commercial PCR assays for the detection of azole-resistant Aspergillus fumigatus from respiratory samples of immunocompromised patients","volume":"7","author":"Scharmann","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0515","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/myc.13428","article-title":"Aspergillus-PCR in bronchoalveolar lavage \u2013 diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients","volume":"65","author":"Mikulska","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0520","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad420","article-title":"Superior accuracy of Aspergillus plasma cell-free DNA PCR over serum galactomannan for the diagnosis of invasive aspergillosis","author":"Mah","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0525","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cid\/ciad141","article-title":"Clinical impact of polymerase chain reaction-based aspergillus and azole resistance detection in invasive aspergillosis: a prospective multicenter study","volume":"77","author":"Huygens","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0530","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0535","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0540","article-title":"Isavuconazole: mechanism of action, clinical efficacy, and resistance","volume":"6","author":"Ellsworth","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0545","doi-asserted-by":"crossref","first-page":"e0017722","DOI":"10.1128\/aac.00177-22","article-title":"New perspectives on antimicrobial agents: isavuconazole","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medcli.2024.01.045_bib0550","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.01.045_bib0555","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/myc.13469","article-title":"Isavuconazole therapeutic drug monitoring in critically ill ICU patients: a monocentric retrospective analysis","volume":"65","author":"H\u00f6hl","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0560","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2018.03.018","article-title":"Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI","volume":"37","author":"Garcia-Vidal","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"10.1016\/j.medcli.2024.01.045_bib0565","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0570","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/myc.12911","article-title":"Posaconazole salvage therapy: the Posifi study","volume":"62","author":"Fortun","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.medcli.2024.01.045_bib0575","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.01.045_bib0580","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.medcli.2024.01.045_bib0585","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid2701.202896","article-title":"Aspergillosis complicating severe coronavirus disease","volume":"27","author":"Marr","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0590","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/cid\/ciz1195","article-title":"How long do we need to treat an invasive mold disease in hematology patients? Factors influencing duration of therapy and future questions","volume":"71","author":"Fernandez-Cruz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2024.01.045_bib0595","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2024.01.045_bib0600","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/jac\/dkaa281","article-title":"Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: when management reasoning eclipses evidence-based medicine","volume":"75","author":"Garcia-Vidal","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T12:55:59Z","timestamp":1723812959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0025775324001933"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.01.045","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive aspergillosis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}